Indeed, we were able to demonstrate increased frequencies of CD4+NKG2D+ T cells in the CSF of RRMS patients compared with healthy controls with even higher frequencies in the active phases of MS, suggesting an association of NKG2D expression with disease activity. Here, KLRK1 is linked to myeloid sarcoma.